Animal Pharma Świebodzinsp. z o.o.

Veterinary activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-08-01
Share capital
15,000.00 PLN
Registered address
ul. Dąbrowszczaków 39/-, 10-542 Olsztyn, Poland
Electronic delivery address
AE:PL-83276-58198-EJGAE-15

Financials

From the notes

Current income tax (CIT due)$153,471

Filing timeliness

The financial statement for 2025 was filed on time.

  • 202502/07/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Veterinary activities31 / 230
Top 13%
Division · Veterinary activities31 / 230
Top 13%
Top 7.1%
City · Olsztyn243 / 1,895
Top 13%
Voivodeship · Warmińsko-Mazurskie973 / 5,933
Top 16%
Country · Poland49,854 / 297,873
Top 17%

Results vs industry

Revenue
This companyUSD 2.78mMedianUSD 406.67kAverageUSD 1.46m
Net profit
This companyUSD 639.34kMedianUSD 16.49kAverageUSD 68.17k
Operating costs
This companyUSD 1.98mMedianUSD 372.03kAverageUSD 1.29m
Assets
This companyUSD 2.19mMedianUSD 144.73kAverageUSD 1.03m

Authorized Representatives

Janusz Henryk Pieczkowski – Management Board Member
Tomasz Maciej Kruszyński – Management Board Member

Manner of representation

One-person representation.

Ownership

OwnerSharesShare valueStake
Jp Trust Fundacja Rodzinna
33$1,337.1233%
Kr Trust Fundacja Rodzinna
17$688.8217%
Tk Trust Fundacja Rodzinna
50$2,025.9350%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2008-10-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,291
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$968

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

FAQ

Last updated: 2026-07-04